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OBJECTIVES: To examine the relationship between in-
somnia, hypnotic use, falls, and hip fractures in older people.
DESIGN: Secondary analysis of a large, longitudinal, as-
sessment database.
SETTING: Four hundred thirty-seven nursing homes in
Michigan.
PARTICIPANTS: Residents aged 65 and older in 2001
with a baseline Minimum Data Set assessment and a follow-
up 150 to 210 days later.
MEASUREMENTS: Logistic regression modeled any fol-
low-up report of fall or hip fracture. Predictors were base-
line reports of insomnia (previous month) and use of
hypnotics (previous week). Potential confounds taken into
account included standard measures of functional status,
cognitive status, intensity of resource utilization, proximity
to death, illness burden, number of medications, emergency
room visits, nursing home new admission, age, and sex.
RESULTS: In 34,163 nursing home residents (76% wom-
en, mean age  standard deviation 84  8), hypnotic use
did not predict falls (adjusted odds ratio (AOR) 5 1.13,
95% confidence interval (CI) 5 0.98, 1.30). In contrast, in-
somnia did predict future falls (AOR 5 1.52, 95%
CI 5 1.38, 1.66). Untreated insomnia (AOR 5 1.55, 95%
CI 5 1.41, 1.71) and hypnotic-treated (unresponsive) in-
somnia (AOR 5 1.32, 95% CI 5 1.02, 1.70) predicted
more falls than did the absence of insomnia. After adjust-
ment for confounding variables, insomnia and hypnotic use
were not associated with subsequent hip fracture.
CONCLUSION: In elderly nursing home residents, insom-
nia, but not hypnotic use, is associated with a greater risk
of subsequent falls. Future studies will need to confirm
these findings and determine whether appropriate hypnotic
use can protect against future falls. J Am Geriatr Soc
53:955–962, 2005.
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More than one-third of adults aged 65 and older falleach year.1 In this age group, falls are the leading
cause of injury-related deaths2 and the most common cause
of nonfatal injuries and hospital admissions for trauma.3
About 1% of falls result in hip fractures that cause restrict-
ed mobility for 60%, increased functional dependence for
25%, death within 6 months for 25%, and annual medical
costs of $2 billion.4 Among the many causes of falls in older
persons are medical conditions, impaired vision and hear-
ing, misuse of assistive devices, environmental factors, and
medications.
Of medications commonly used by older persons, psy-
chotropic agents and hypnotics in particular have been im-
plicated as strong risk factors for falls.5–8 In a community
setting, psychotropic or sedative use increased the likeli-
hood of falls by a factor of 28.3 (95% confidence interval
(CI) 5 3.4–239.4), after controlling for some other risk fac-
tors.9 In comparison, cognitive impairment only increased
fall risk by a factor of 5.0 (95% CI 5 1.8–13.7) and mul-
tiple balance and gait abnormalities by a factor of 1.9 (95%
CI 5 1.0–3.7). Sedatives can impair posture, reaction time,
coordination, protective responses during falls, and cardio-
vascular reflexes that normally prevent orthostatic hypo-
tension,10–12 but much of the measured effect of sedative
use also may be attributable to unmeasured health condi-
tions and practices common in sedative usersFinclud-
ing comorbidities, decreased coordination, cognitive
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dysfunction, impaired mobility, and sedative polypharma-
cyFrather than to a causative link between single sedative
use and falls or hip fracture.13–15
Furthermore, most studies that have implicated hyp-
notics as risk factors for falls and injuries did not explore
the possibility that underlying insomnia, rather than med-
ication, could be the main reason for the adverse out-
comes.16 In a community-based cross-sectional survey of
1,526 older adults, insomnia, but not psychoactive medi-
cation, was associated with falls within the previous 12
months,17 although use of psychoactive agents was rare
(4%) in this relatively well-educated Silicon Valley com-
munity. Neither this study nor others of insomnia or hyp-
notics in older persons have combined sufficient sample
size, adjustment for the large number of potential covari-
ates, and a longitudinal design to confirm that putative risk
factors precede outcomes. A better understanding of wheth-
er hypnotics, underlying insomnia, both, or neither con-
tribute to falls could inform interventions likely to have
substantial effect on the health of institutionalized older
people. To address this question, a statewide, government-
mandated nursing home database that contains infor-
mation about sleep, falls, health, and many covariates
collected longitudinally at 3-month intervals was used.
METHODS
Subjects and Database
Data for this study were obtained from assessments of all
residents of nursing home facilities in Michigan that qualify
for federal funding under Medicare or Medicaid. In com-
pliance with the Omnibus Reconciliation Act of 1987, these
residents are assessed at least four times each year using the
Long-Term Care Facility Resident Assessment Instrument,
a comprehensive, standardized assessment instrument that
includes the Minimum Data Set (MDS). The MDS includes
350 items on demographics; health conditions; cognitive,
physical, emotional, and social functioning; medical diag-
noses; therapies; treatments; and medication use. Full as-
sessments occur at admission, when significant changes in
health status occur, and at least annually. Quarterly assess-
ments that cover fewer items occur approximately every 90
days after admission. Trained assessors at each facility use
all available sources of information (e.g., the resident, fa-
cility staff, resident’s physician, and medical chart) to de-
termine the most appropriate response for each assessment
item. The University of Michigan medical institutional re-
view board approved use of the Michigan MDS data for the
purposes of this research.
For this analysis, the sample includes all nursing home
residents, both newly admitted and long-stay, aged 65 and
older who had a full assessment in 2001 (January 1, 2001,
to December 31, 2001) and a follow-up assessment ap-
proximately 6 months (150–210 days) later. When more
than one full assessment in 2001 was available, the earliest
assessment was used. By these criteria, there were 34,163
available subjects (Figure 1).
Measures
The Resident Assessment Instrument/Minimum Data Set
2.0 (RAI/MDS 2.0) was designed to improve care planning
and therefore covers a broad range of domains, including
physical and cognitive function, continence, mood, medical
diagnoses and conditions, activity patterns, medications,
and changes in physical status. Five items from the MDS
were used: insomnia (E1k), hypnotic use (O4d), hip fracture
(J4c), falls in previous 30 days (J4a), and falls in previous 31
to 180 days (J4b). Since implementation in 1991, the items
included in the MDS have performed well in tests of reli-
ability and validity,18 as have scales derived from the MDS
items. Several reliability studies have examined interob-
server reproducibility, which is the agreement between two
assessors who independently evaluate the same
resident.18–21 Spearman-Brown intraclass correlation coef-
ficients for each section of the MDS between contempora-
neous ratings by two research nurses range from 0.46 to
0.78.22 Reproducibilities for the independent variables used
in the present analysis were 0.53 for insomnia; 0.62 for
hypnotic use, 0.70 for hip fracture, 0.66 for falls in previous
30 days, and 0.69 for falls in previous 31 to 180 days
(Morris JN, personal communication, 2004). A recent
large-scale reliability trial of the MDS, with more than
5,700 dual assessments performed by facility staff during
routine operation and research assessors in six states and
219 facilities, demonstrated average to good reliability.23
Scales derived within selected domains of the MDS
demonstrate concurrent validity through high correlation
with other frequently used measures. For example, the
Cognitive Performance Scale,24 derived from the MDS,
correlates highly with the Folstein Mini-Mental State Ex-
amination25 and the Albert Test of Severe Impairment.26 In
addition, a national evaluation of the full RAI system dem-
onstrated the system’s effectiveness in care improvement;
after implementation of the RAI, falls were reduced,27–30
which suggests criterion validity. The RAI/MDS is a re-
source for research as well as for care planning;31 as of April
2004, Medline indexed 527 articles that used the MDS.
Explanatory Variables and Potential Confounders
Potential effects of insomnia and hypnotic use on falls and
hip fractures were studied, after adjustment for a number of
Figure 1. Identification of the 34,163 subjects whose data were
used for this study.
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general health status indicators. All explanatory variables
and potential confounders were obtained from the baseline
MDS assessment. Residents with insomnia/change in usual
sleep pattern on any of the preceding 30 days were coded as
having insomnia. Residents who had received a hypnotic
medication during the previous 7 days were coded as using
a hypnotic. Hypnotics as defined by the MDS 2.0 User’s
Manual32 included aprobarbital, flurazepam, quazepam,
triazolam, pentobarbital, ethchlorvynol, estazolam, tema-
zepam and secobarbital, although any drug considered to
be a hypnotic would be coded as a hypnotic, regardless of
the indication, as recommended by the Centers for Medi-
care and Medicaid Services when it revised the MDS 2.0
nursing home manual in 2001 (Belleville-Taylor P, personal
communications, 2004). Additional drugs in this classifi-
cation may be determined by consulting a drug reference
source such as the U.S. Pharmacopeia Formulary, the Phy-
sician’s Desk Reference, or the Merck Index; zolpidem and
zaleplon are classified as hypnotics in these sources. Note
that a hypnotic used off label for another purpose would
still be coded as a hypnotic, whereas a drug not classified as
a hypnotic (e.g., an anxiolytic) would not be coded as a
hypnotic, even if intended to promote sleep.
Fifty-four percent of the residents who had received a
hypnotic in the previous week received it on five or more
days. Other fall-related resident characteristics (resident
age, sex, functional and cognitive status, intensity of re-
source utilization, burden of illness, number of medications
taken, emergency department visits, and new admission)
were controlled for. Functional status (ability in locomo-
tion, transferring, toileting, and eating) was measured using
the activity of daily living hierarchy scale,33 cognitive status
(memory, decision making, understanding) using the Cog-
nitive Performance Scale,24 intensity of resource utilization
using the Resource Utilization Group (RUG)-III category
and Case Mix Index,34 burden of illness using the Changes
in Health, End-stage disease and Symptoms and Signs
scale35 and the Personal Severity Score (unpublished data),
polypharmacy using the number of medications taken, and
recent changes in health status using any emergency de-
partment visit in the previous 90 days not resulting in ad-
mission to the hospital and admission to the nursing home.
Outcome Measures
Two outcomes were examinedFfalls and hip frac-
turesFthat occurred in the 6 months between the baseline
and follow-up assessments. Both were coded from the fol-
low-up assessment. A fall was coded if the resident had
fallen in the previous 30 days or in the previous 31 to 180
days. A hip fracture was coded if a hip fracture occurred in
the previous 180 days.
Analysis
Within the sample of 2,001 Michigan nursing home resi-
dents aged 65 and older who had a 6-month follow-up, the
data were checked for completeness. In the few cases in
which a value was missing for one independent variable but
present for all others, the most common value (discrete
variables) or the mean (continuous variables) was imputed.
The Pearson chi-square test was then used for discrete var-
iables and the Student t test for continuous variables to
examine the bivariate (unadjusted) associations between
outcome variables, explanatory variables, and potential
confounders. To examine the effect of insomnia, hypnotic
use, and both insomnia and hypnotic use after controlling
for confounding, multivariate logistic regression models
were created. The combined effect of insomnia and hyp-
notic use on falls and hip fracture was evaluated using a
four-categorical variable representing insomnia without
hypnotic use, insomnia despite hypnotic use, hypnotic use
without current insomnia, and neither insomnia nor hyp-
notic use. Relationships between explanatory and con-
founding variables and outcomes were considered
significant when Po.05. Three potential confoundersFvi-
sion, Personal Severity Index, and Case Mix IndexFwere
significant in bivariate but not in multivariate models.
Therefore, these variables were removed from subsequent
logistic regression models.
RESULTS
Descriptive statistics and item identifiers for outcomes,
baseline explanatory variables, demographics, and other
potential confounding variables are shown in Table 1 for
the study sample and those excluded for lack of follow-up
data. The study sample largely reflects long-term nursing
home residents, whereas those without a 6-month follow-
up were likely to have been in the nursing home for post-
acute, rehabilitation, or terminal care. Accordingly, the ex-
cluded sample was more likely to have been recently
admitted to the nursing home, to have had an emergency
room visit, and have higher burden of illness; those exclud-
ed used more medications, were less able to balance well,
and were more functionally impaired. Insomnia and hyp-
notic use were more frequent in the excluded sample. Al-
ternatively, the study sample had a greater proportion of
women and was, on average, 2 years older, more cognitively
impaired, more visually impaired, and more likely to be in a
clinically intense RUG-III category.
Of the 34,163 subjects in this study, 14,661 (42.9%)
were reported to have fallen in the 6-month period (mean of
174 days) between their baseline and follow-up evalua-
tions, whereas 841 (2.5%) were reported to have sustained
a hip fracture. Almost all (90.3%) of the subjects who sus-
tained a hip fracture in the follow-up period experienced at
least one fall (chi-square 5 796.54, Po.001). Moderate in-
somnia (occurring on 1 to 5 nights per week) was reported
in 1,872 (5.5%) subjects, and severe insomnia (6 nights
per week) in 277 (0.81%). Hypnotic use was reported in
882 (2.6%) of the subjects. As expected, insomnia (mod-
erate or severe) was strongly associated with hypnotic use
(chi-square 5 852.97, Po.001); 11.3% of moderate in-
somniacs used some hypnotic, as did 17.3% of severe in-
somniacs.
In the following, falls and hip fractures are described
separately. Table 2 shows the bivariate (unadjusted) rela-
tionship between each explanatory, demographic, and po-
tential confounding variable and each outcome variable.
Increasing age, unsteady balance, use of more medications,
and recent changes in health status as reflected in recent
nursing home admission, a recent emergency department
visit, and increased burden of illness each increased the
likelihood of fall or hip fracture. Risk of fall or hip fracture
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increased with functional and cognitive impairment, until
impairment became severe; this curvilinear pattern is visible
in the greater risks associated with moderate than with se-
vere impairment in functional status, cognitive impairment,
and RUG-III category. Vision problems likewise increased
the risk of falling and hip fracture only for residents capable
of independent locomotion. All explanatory and confound-
ing variables are related to each outcome variable at
Po.05.
Table 3 reports the relationships between falls and hip
fractures and hypnotic use, insomnia, and combinations of
hypnotic use and insomnia. All these associations were ad-
justed for the demographic and confounding variables listed
in Table 2. Additional exploratory adjustment (not shown)
Table 1. Outcomes, Explanatory Variables, Demographics, and Other Potential Confounders for the Study Sample and for
Excluded Subjects







P-value(n 5 34,163) (n 5 39,982)
Outcome variables
(at follow-up), n (%)
Falls J4a, J4b 1 in previous 180 days 14,661 (42.9) Unknown N.A.
Hip fracture J4c 1 in previous 180 days 841 (2.5) Unknown N.A.
Explanatory variables
(at baseline), %
Insomnia E1k Within previous 30 days 6.3 10.5 o.001
Hypnotic use O4d At least once in previous 7 days 2.6 6.9 o.001
Demographics
Age, mean  SD AA3 84.2  7.7 82.6  7.7 o.001
Women, % AA2 76.5 66.6 o.001
Potential confounders
(at baseline)
Activities of daily living G1eA, G1hA, Mildly impaired (0,1,2) 31.5 30.9 o.001
hierarchy scale, % G1iA, G1jA Moderately impaired (3,4) 39.6 34.6
Severely impaired (5,6) 28.8 34.6
Cognitive Performance
Scale, %
B2a, B4, C4 Mildly impaired (0,1) 22.7 46.9 o.001
Moderately impaired (2,3,4) 60.9 42.6
Severely impaired (5) 8.8 4.7
Very severely impaired (6) 7.6 5.9
RUG III Categorization, % H2c, H2e, H2f, H2g Reduced physical function 20.9 56.9 o.001
Behavioral problems 5.0 11.8
Impaired cognition 5.9 7.8
Clinically complex 18.3 10.8
Special care 16.9 3.2
Intensive services, % 0.6 0.2
Special rehabilitation, % 32.4 9.3
Case mix index,
mean  SD
H2c, H2e, H2f, H2g Ratio of RUG III category
hours of
care to average hours of care
1.04  0.61 1.66  0.69 o.001
Burden of illness,
mean  SD
B6, G9, J1b-d, J1l,
J1o, J5c, K3a, K4
Changes in Health, End-stage
disease, and Signs and
Symptoms score (0–6)
1.09  1.08 1.82  1.13 o.001
Personal Severity
Index, %
A3, B4, B5e, G1bA,
G1eA, G1hA,
G1Ja, E1c, E1g, H1a,
J5a–c, K3a, M2a, M2b, Q2
Above mortality threshold (5) 39.3 44.9 o.001
Vision, % D1, D2a, D2b Impaired 42.7 31.8 o.001
Balance test, % G3a Unsteady, needs support, 87.9 93.2 o.001
Polypharmacy, mean  SD O1 Medications 8.3  4.2 9.6  4.5 o.001
Emergency room visit, % P6 1 in previous 90 days 6.4 10.3 o.001
Admission to nursing home, % AA8a Within previous 90 days 23.3 42.3 o.001
SD 5 standard deviation; RUG 5 Resource Utilization Group.
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Table 2. Unadjusted Relationship of Explanatory, Demographic, and Potential Confounding Variables to Outcome
Variables for the Study Sample (N 5 34,163)
Variable n
Falls Hip Fracture
Odds Ratio (95% Confidence Interval)
Explanatory
Insomnia
Yes 2,149 1.90 (1.74–2.07) 1.45 (1.14–1.85)
No 32,014 Ref Ref
Hypnotic use
Yes 882 1.29 (1.13–1.48) 1.46 (1.01–2.10)
No 33,281 Ref Ref
Insomnia, hypnotic use 259 1.54 (1.21–1.97) 1.65 (0.87–3.12)
Insomnia, no hypnotic use 1,890 1.96 (1.79–2.16) 1.44 (1.11–1.87)
No insomnia, hypnotic use 623 1.27 (1.08–1.49) 1.43 (0.92–2.23)
No insomnia, no hypnotic use 31,391 Ref Ref
Demographics
Age
65–75 4,489 Ref Ref
76–85 13,125 1.25 (1.17–1.34) 1.50 (1.17–1.92)
86–95 14,095 1.39 (1.30–1.49) 1.52 (1.19–1.95)
96 2,454 1.38 (1.25–1.53) 1.56 (1.12–2.18)
Sex
Female 26,137 0.80 (0.76–0.84) 1.30 (1.10–1.55)
Male 8,026 Ref Ref
Potential confounders
Activities of daily living hierarchy
Mildly impaired (0,1,2) 1,830 Ref Ref
Moderately impaired (3,4) 13,543 2.10 (1.89–2.33) 2.54 (1.60–4.05)
Severely impaired (5,6) 9,844 1.07 (0.96–1.20) 2.63 (1.64–4.20)
Cognitive Performance Scale
Mildly impaired (0,1) 7,755 Ref Ref
Moderately impaired (2,3,4) 5,289 1.39 (1.30–1.50) 0.84 (0.68–1.03)
Severely impaired (5) 3,015 1.70 (1.57–1.86) 0.71 (0.55–0.94)
Very severely impaired (6) 2,594 0.55 (0.49–0.60) 0.23 (0.14–0.36)
Resource Utilization Group III categorization
Reduced physical function 7,152 Ref Ref
Behavioral problems 1,702 0.78 (0.71–0.87) 0.80 (0.63–1.01)
Impaired cognition 2,026 0.39 (0.35–0.43) 0.42 (0.32–0.56)
Clinically complex 6,236 0.55 (0.52–0.59) 0.16 (0.12–0.21)
Special care 5,776 0.82 (0.77–0.88) 0.24 (0.19–0.30)
Intensive services 194 0.60 (0.45–0.80) 0.24 (0.08–0.75)
Special rehabilitation 11,077 0.45 (0.43–0.48) 0.14 (0.11–0.17)
Case Mix Index 34,163 1.19 (1.10–1.14) 37.34 (34.89–39.97)
Burden of illness (Changes in Health, End-stage disease, and Signs and Symptoms)
Low predicted mortality (0) 12,342 Ref Ref
Some predicted mortality (1–6) 21,285 1.64 (1.57–1.72) 3.35 (2.76–4.06)
Personal Severity Index
Below mortality threshold (0–4) 20,754 Ref Ref
Above mortality threshold (5) 13,409 0.93 (0.89–0.97) 1.36 (1.19–1.56)
Vision
Impaired 14,545 0.94 (0.90–0.99) 0.75 (0.65–0.86)
Not impaired 19,521 Ref Ref
Balance test
Unsteady/needs support 4,134 1.18 (1.11–1.26) 1.56 (1.21–2.00)
Steady 29,994 Ref Ref
Polypharmacy (medications)
0 275 Ref Ref
1–5 8,736 1.46 (1.13–1.89) 1.62 (0.51–5.10)
6–10 16,236 1.74 (1.35–2.25) 2.28 (0.73–7.14)
11–15 7,307 1.75 (1.35–2.27) 2.81 (0.90–8.85)
(Continued )
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for the following specific medical comorbidities had essen-
tially no effect on model results: cerebrovascular disease,
dementia, hypertension, hypotension, seizure disorder, ath-
erosclerotic heart disease, congestive heart failure, periph-
eral vascular disease, chronic obstructive pulmonary
disease, hemiplegia, renal failure, diabetes mellitus, human
immunodeficiency virus, and cancer.
Falls
In a bivariate model, baseline hypnotic use predicted a 29%
greater risk and baseline insomnia predicted a 90% greater
risk for future falls (odds ratios of 1.29 and 1.90, respec-
tively, Table 2). After adjustment for age, sex, and all other
potential confounders listed in Table 1, hypnotic use did not
predict a significantly greater risk for future falls, whereas
insomnia at baseline still predicted a 52% greater risk (Ta-
ble 3).
In comparison with subjects with no baseline insomnia
or hypnotic use, insomniacs who took no hypnotics had an
adjusted 55% greater risk for future falls (Po.001). Sim-
ilarly, subjects reported to have insomnia despite use of
hypnotics had a 32% greater risk for future falls (P 5.03).
In contrast, subjects who took hypnotics but did not have
concurrent insomnia had no significantly greater risk for
future falls (P 5.22).
Dose-Response Relationship
Subjects reported to have moderate insomnia (1–5 nights
per week) at baseline were 47% more likely to fall in the
follow-up period (odds ratio (OR) 5 1.4, 95% CI 5 1.33,
1.63) than those with no insomnia. Subjects reported to
have severe insomnia (6 nights per week) were 86% more
likely to experience future falls (adjusted OR 5 1.86, 95%
CI 5 1.44, 2.39).
Hip Fractures
In bivariate models, baseline hypnotic use predicted a 46%
greater risk of future hip fracture, and baseline insomnia
predicted a 45% greater risk (Table 2). After adjustment for
age, sex, and all other potential confounders listed in Table
1, baseline hypnotic use, insomnia, and combinations of the
two failed to predict future hip fracture (Table 3).
DISCUSSION
This statewide study of older Michigan nursing home res-
idents shows that, after adjustment for a wide range of
possible confounding variables, insomnia, but not hypnotic
use, is associated with subsequent falls. The data raise the
question of whether hypnotic use had a protective effect;
nursing home residents who took hypnotics but did not
have insomnia showed no greater risk of falls, perhaps be-
cause the condition was well treated. These findings derive
from a study unique in size, sample representativeness, lon-
gitudinal design, and strength of controls for potential con-
founders. The sample composition minimizes selection bias.
Longitudinal design ensured that measured insomnia and
hypnotic use preceded falls and hip fractures. Adjustment
for multiple potential confounds rendered nonsignificant
the association between hypnotics and falls but did not
eliminate the association between insomnia and falls. Fur-
thermore, insomnia predicted future falls in a dose-depend-
ent manner.
These data are among the first to suggest that current
hypnotics may not make a major contribution to falls, or
hip fractures, in institutionalized older people. Previous
studies that reported such associations may not have ad-
justed effectively for multiple confounders, assessed wheth-
er insomnia is a key confounder, or used a longitudinal
research design. Another difference between this study and
older ones may be that the latter enrolled subjects using
primarily benzodiazepines. More recently released non-
benzodiazepine hypnotics, such as zolpidem and zaleplon,
have short half-lives and may have less cognitive effect than
older medications.36 Perhaps in part for this reason, the
fully adjusted models suggest that, when insomnia is not an
active problem, patients on hypnotics have no increased
risk for falls. These data could support the speculation that
reduction of insomnia using short-acting, nonbenzodiaze-
pine hypnotics may actually reduce the risk for subsequent
falls.
There are several possible mechanisms by which in-
somnia could increase the risk of falls. Sleep loss causes
excessive daytime sleepiness, cognitive dysfunction, and
decreased psychomotor performance. Reaction time is par-
ticularly sensitive.37,38 Studies of falls in older persons have
implicated small changes in the velocity of lower extremity




Odds Ratio (95% Confidence Interval)
16–25 1,579 1.55 (1.18–2.04) 3.89 (1.21–12.5)
26 30 1.47 (0.68–3.18) 6.48 (1.04–40.41)
Emergency department visit
Yes 2,200 1.48 (1.35–1.61) 1.57 (1.24–1.98)
No 31,949
Admission to nursing home
Yes 7,953 1.86 (1.77–1.96) 2.06 (1.78–2.37)
No 26,210
Ref 5 reference.
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imminent fall could arise from slowed danger perception,
response calculation, or motor command generation. Stud-
ies in occupational or emergency department settings show
that sleep problems and decreased sleep often precede trau-
matic accidents.39,41 Excessive daytime sleepiness is a major
cause of motor vehicle crashes, in part because of psycho-
motor impairment rivaling that seen with alcohol intoxi-
cation.42 However, simpler reasons also may explain an
effect of insomnia on fall risk; for example, insomnia could
cause falls in older people because it increases the likelihood
of nocturnal ambulation.17
The data from the current study do not implicate hyp-
notic use as a risk factor for hip fracture. Whereas lack of
sufficient statistical power has been blamed for failure in
other studies to prove an effect of fall prevention interven-
tion on serious injury, including hip fracture,43 the current
study had a sample size adequate to detect these relation-
ships if present. Hypnotic use is only marginally related to
hip fracture even on a bivariate basis; when insomnia is
included in any model of hypnotic use, neither falls nor hip
fractures are related to hypnotic use. These results support
the inference that insomnia drives the association between
hypnotic use and falls.
Findings from this study must be interpreted with cau-
tion. This two-wave observational design does not allow
strong causal inference, such as might derive from a pro-
spective randomized clinical trial or even from a multiwave
observational study that follows hypnotic use and insomnia
in specific individuals. Large population studies based on
secondary data from routine administrative sources often
include variables of interest that are not validated against
criterion-standard measures or for which no criterion
standards exist.5 In this case, insomnia, hypnotic use, falls,
and hip fractures were all ascertained using single MDS
items that have not specifically been validated against other
criterion-standard measures. Also, unintentional preferen-
tial coding for insomnia could have occurred when nursing
home staff knew that individuals used hypnotics. Fortu-
nately, the item about insomnia precedes that about hyp-
notics and is located in a different section, which would
reduce the likelihood of this bias.
There are several interpretation questions associated
with the use of MDS data. MDS data are recorded in com-
pliance with specific definitions; understanding these def-
initions aids in interpretation of these findings. In the MDS,
insomnia is a symptom rather than a diagnosis, and the
many different causes for insomnia could have divergent
relationships with falls or hip fractures. As defined using the
MDS 2.0 User’s Manual, insomnia is defined as ‘‘difficulties
falling asleep, waking up too early and being unable to fall
back asleep.’’31 Although insomnia can be classified into
primary and secondary insomnia, and primary insomnia
can further be classified as intrinsic (endogenous) and ex-
trinsic (reactive to a specific trigger), the MDS does not
distinguish between these forms, permitting several possible
causal mechanisms. Also, insomnia has the weakest relia-
bility of the study variables. Still, when insomnia is coded, it
seems to have an important effect on falls and hip fractures.
Furthermore, the medications identified as hypnotics on the
MDS and hence in this study do not include other medi-
cations that may be prescribed for those with sleep diffi-
culties, such as diphenhydramine and trazodone. Therefore,
these conclusions are restricted to medications classified as
hypnotics.
Use of MDS data also raises timing issues. Hypnotic use
and insomnia were only available from the first assessment
and not during the entire follow-up period. In some cases,
hypnotic use or insomnia may have been started or stopped
during the 6-month follow-up period and would not be
reflected in MDS records. Such potential discontinuity
could have affected the precision of the analyses, but is
unlikely to have affected a sufficiently large portion of the
sample to affect the robust basic relationships reported. If
hypnotic use were discontinued because of fall-related in-
dications (such as daytime sedation or unsteadiness), the
inference that hypnotics can be used successfully in this
population will be overstated. Inferences on the benefits of
insomnia reduction would be unaffected.
The mechanisms by which insomnia could contribute
to falls were not explored in this study, although none of the
many covariates tested, such as overall burden of illness or
intensity of resource utilization, appears to be a sufficiently





n Odds Ratio (95% Confidence Interval)
Insomnia
Yes 2,149 1.52 (1.38–1.66) 0.99 (0.77–1.26)
No 32,014 Ref Ref
Hypnotic use
Yes 882 1.13 (0.98–1.30) 0.85 (0.58–1.22)
No 33,281 Ref Ref
Insomnia, hypnotic use 259 1.32 (1.02–1.70) 0.92 (0.48–1.76)
Insomnia, no hypnotic use 1,890 1.55 (1.41–1.71) 0.99 (0.76–1.30)
No insomnia, hypnotic use 623 1.11 (0.94–1.31) 0.81 (0.52–1.27)
No insomnia, no hypnotic use 31,391 Ref Ref
Note: These models controlled for age, sex, functional status, cognitive status, intensity of resource utilization, burden of illness, number of medications taken,
emergency department visits, and new admission.
Ref 5 reference.
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strong intermediary variable to eliminate the primary rela-
tionship. The lack of association between hypnotics and
falls results from adjustment for potential confounders; in
reality these variables may act as important intermediary
variables in a causal pathway. For example, if hypnotic use
increases fall risk only through impairment of locomotion,
then adjustment for locomotion performance could have
obscured the effect of hypnotics. Until the pathophysiology
of falls in older people is better understood, optimal choices
of covariates in such models will be challenging.
Despite these limitations, findings from this study have
important implications for future research and possibly for
clinical practice. In the nursing home setting, untreated in-
somnia may be a more important problem than previously
recognized. Although nonpharmacological treatments for
insomnia are usually preferable to hypnotics (unpublished
data), the data from the current study raise the question of
whether effective use of selected hypnotics, including short-
acting nonbenzodiazepine hypnotics, also may reduce fall
risk. Future research should address this hypothesis more
directly and should include institutionalized older people,
for whom insomnia and falls may be particularly prevalent
causes of medical morbidity.
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